AMRI Announces Third Quarter 2014 Results
ALBANY, N.Y., Nov. 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter endedSeptember 30, 2014. Total revenue for the third quarter of 2014 was $62.5 million, an increase of 3% compared to total revenue of$60.8 million reported in the t...
AMRI to Announce Third Quarter Results on November 5, 2014
ALBANY, N.Y., Oct. 24, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue third quarter financial results before the opening of the U.S. financial markets onWednesday, November 5, 2014. Following the release of its results, the company will host a conference call and simul...
New Platforms Enhance AMRI's Discovery Biology Offerings
ALBANY, N.Y., Sept. 4, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of ...
AMRI CEO to Present at the Morgan Stanley Global Healthcare Conference
ALBANY, N.Y., Aug. 26, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today thatWilliam S. Marth, President and Chief Executive Officer at AMRI, will present at the Morgan Stanley Global Healthcare Conference onMonday, September 8, 2014 at 8:45 a.m. ET. A live audi...
AMRI Announces Second Quarter 2014 Results
ALBANY, New York, Aug. 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter endedJune 30, 2014. Highlights: * Second quarter contract revenue of $61.5 million, up 21% from 2013 * Second quarter adjusted diluted EPS of $0.22 vs. $...
AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing
ALBANY, N.Y., July 2, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent suppli...
AMRI CEO to Present at the Jefferies 2014 Global Healthcare Conference
ALBANY, N.Y., May 19, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 3:30 p.m. ET. A webcast of the pr...
AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.
ALBANY, N.Y., April 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc. Cedarburg, whose capabilities both augment and complement those of AMRI, is a contract developer and manufacturer of technica...
AMRI to Acquire Cedarburg Pharmaceuticals, Inc.
- Broadens Contract Development and Manufacturing Capabilities with High Value, Complex API Business - - Transaction Expected to add between $0.06 and $0.07 to Adjusted Diluted EPS in 2014 - ALBANY, New York, March 24, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has signed...
AMRI CEO to Present at Barclays Global Healthcare Conference
ALBANY, N.Y., Feb. 27, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at Barclays Global Healthcare Conference on Wednesday, March 12, 2014 at 2:00 p.m. ET. A webcast of the pres...
AMRI Announces Fourth Quarter and Full Year 2013 Results and Provides 2014 Guidance
-- Full Year 2013 Contract Revenue Growth of 11% to $210 Million and Adjusted Diluted EPS of $0.70 ALBANY, N.Y., Feb. 12, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter and Ful...
AMRI Hires George Svokos as Senior Vice President Sales and General Manager – API
-- Leadership Appointment Bolsters API Business and Sales Strategies ALBANY, New York, Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of George Svokos, to the newly created position of Senior Vice President Sales and General Manager API...
AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India
AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India - Leadership Appointment Bolsters API Business and Leadership Team ALBANY, New York, Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of Vijay Kumar Batra, to the position o...
AMRI CEO to Present at the 32nd Annual J.P. Morgan Healthcare Conference
ALBANY, New York, Jan. 9, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 7:30 a.m. PT. A web...
